West Syndrome Market Size & Share, by Product Type {Solid Dosage (Tablet, Capsule), Liquid Dosage (Injectable)}; Administration Route (Parenteral, Oral); Treatment (Anticonvulsant, Benzodiazepine, Corticosteroids, Vitamin B); Distribution Channel (Retail, Online, Hospitals); End-user (Hospitals, Homecare, Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4397
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2033

West Syndrome Market size is estimated to cross USD 3 Billion by the end of 2033, growing at a CAGR of 5% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of west syndrome was USD 1 billion. The growth of the market can be attributed to the rising prevalence of epilepsy. The World Health Organization (WHO) provided a report stating that nearly 5 million individuals are diagnosed with epilepsy every year worldwide. Epilepsy is one of the most common chronic disorders across the world. It is a non-communicable disease that affects the central nervous system and causes physical impairment of the body. The recurrent seizures cause discomfort in movement eventually leading to paralysis. It is mainly caused by brain damage, head injury, absence of oxygen, brain infection, brain tumor, meningitis, encephalitis, and neurocysticercosis.

Global west syndrome market trends such as growing awareness of west syndrome in the global population and rising healthcare expenditure are projected to influence the growth of the market positively over the forecast period. In a report published by the World Bank, it was stated that in 2019, the healthcare expenditure reached 1,121.9 per capita. West syndrome is a serious medical condition with a drastically irregular pattern of brain waves which is also known as hypsarrhythmia. West syndrome also includes features such as infantile spasms and loss of developmental milestones. Moreover, spiking R&D spending on neurological illnesses and the rising inclination of the global population toward novel therapies are further anticipated to propel the growth of the market over the forecast period.

Get more information on this report: Request Free Sample PDF

West Syndrome Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Incidence of Traumatic Brain Injuries to Boost the Market Growth - As of 2019, around 200,000 people were noticed to be hospitalized while nearly 62,000 people died due to traumatic brain injuries in the same year in United States. Traumatic brain injury, shortly known as TBI can affect the functionality of the brain in multiple ways. It is categorized into two categories that are closed and penetrating brain injury. TBI can also cause death and serious disabilities becoming the major cause of death in the United States. Hence, such a higher prevalence is estimated to hike the market growth over the forecast period.

  • Higher Prevalence of Drug Seizure - In 2022-21, about 5500 drug seizures per million inhabitants were observed solely in London.

  • Significant Growth in the Imaging Technology - For instance, the diagnostic imaging devices segment was valued at nearly USD 45 billion in 2022 worldwide.

  • Growing Penetration of Neurological Disorders - Based on the data released by Pan American Health Organization (PAHO), in 2019, about 533,172 people died due to neurological conditions in the United States.


  • Shortage of Requisite Equipment and Skilled Medical Professionals - The brain is one of the main organs that helps to regulate movement, coordination, intelligence, and all cognitive functions. So, only a skilled professional can treat the diagnose a disease perfectly. Any errors in the diagnosis will harm the patient. And it is not possible to make skilled doctors available at all times in a hospital which may hinder market growth.
  • Lack of Awareness in the Rural Areas
  • Higher Cost Associated with the Treatment

West Syndrome Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~ USD 1 Billion

Forecast Year Market Size (2033)

~ USD 3 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

West Syndrome Segmentation

Product Type {Solid Dosage (Tablet, Capsule), Liquid Dosage (Injectable)}

The global west syndrome market is segmented and analyzed for demand and supply by product type into solid dosage (tablet and capsule), and liquid dosage (injectable and others), out of which, the solid dosage segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the rising consumption of medicine across the globe. For instance, in 2021, global medicine spending was estimated to be nearly USD 1 trillion. The increasing health issues faced by people every day owing to rising chemical food, and an improper nutrient diet leads to suppressed immunity in young and adults. The increasing population of adults across the globe with growing longevity and early diagnosis of diseases is estimated to boost the market growth during the forecast period. The increasing occurrence of chronic diseases such as diabetes, cancer, blood pressure, and cholesterol require lifelong medications for proper regulation and prevention of further complications.

Distribution Channel (Retail, Online, Hospitals)

The global west syndrome market is also segmented and analyzed for demand and supply by distribution channel into retail, online, and hospitals. Amongst these three segments, the hospitals segment is expected to garner a significant share. Hospitals are the place where more patients come for chronic and serious disease treatment. The increasing number of chronic diseases worldwide is estimated to boost the growth of the market during the forecast period. According to the Centers for Disease Control and Prevention, 6 members out of 10 in the U.S. are suffering from chronic disease. The increasing healthcare sector is expanding with a growing number of diseases that are contagious such as COVID-19. West syndrome is a disorder of brain function that can cause impairment of body parts. Epilepsy and seizures are the side effects of west syndrome which need complete nervous treatment. The increasing disposable income and rising awareness of people are estimated to increase the growth of hospitals which in turn increases the market growth during the forecast period.

Our in-depth analysis of the global market includes the following segments:

          By Product Type

  • Solid Dosage
  • Tablet
  • Capsule
  • Liquid Dosage
  • Injectable
  • Others

            By Administration Route

  • Parenteral
  • Oral
  • Others

           By Treatment

  • Anticonvulsant
  • Benzodiazepine
  • Corticosteroids
  • Vitamin B

          By Distribution Channel

  • Retail
  • Online
  • Hospitals

           By End-User

  • Hospitals
  • Homecare
  • Clinics

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

West Syndrome Industry - Regional Synopsis

North American Market Forecast   

The North American west syndrome market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the escalation in the number of people living with traumatic brain injuries. For instance, in 2020, more than 60,000 people lost their lives due to traumatic brain injuries solely in the USA while approximately 150 death occurs on a daily basis in the same region. The increasing number of accidents on road cause brain damage or brain injury. The growing number of brain surgeries owing to infection, cancer, or side effect of any disease are estimated to rise market growth. Accidents in sports are also rising owing to the increasing preference of people for fitness and physical activity. Brain diseases can also be caused by genetic disorders that occur during birth.

APAC Market Statistics

Moreover, the second largest market share is occupied by the Asia Pacific region. The growth of the market is attributed to the increasing prevalence of diseases, improvement in the healthcare sector, and growing awareness of treatment among people. The rising healthcare infrastructure and facilities in the countries of the Asia Pacific region including China and India play a major role in the market growth. As per the research, it is reported that the healthcare expenditure of China in 2020 was estimated to be USD 1 trillion

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the West Syndrome Landscape

    • Marinus Pharmaceuticals, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • SK Biopharmaceuticals Co., Ltd.
    • Alkem Laboratories Ltd.
    • Supernus Pharmaceuticals, Inc.
    • Eisai Co., Ltd.
    • Abbott Laboratories
    • Upsher-Smith Laboratories, LLC.
    • Pfizer Inc.
    • H. Lundbeck A/S
    • UCB S.A.


In The News

  • Eisai Co., Ltd. to announce its first presentation with Merck & Co., Inc. associated with the Phase 3 LEAP-002 trial investigating LENVIMA, a receptor tyrosine, orally available and discovered by Eisai. Furthermore, the anti-PD-1 therapy, plus KEYTRUSA, from Merck & Co., Inc., is also introduced as a first-line treatment for uHCC.

  • SK Biopharmaceuticals Co., Ltd. to announce the result of the long-term randomized open-label extension (OLE). The company is focused on treatment development for central nervous system (CNS) disorders. Data analyzed in the OLE phase was taken from nearly 335 adult patients having focal seizures. from nearly 355 adult patients having focal seizures.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4397
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Higher prevalence of drug seizures and significant growth in imaging technology are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2023-2033.

Shortage of requisite equipment and skilled medical professionals are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are SK Biopharmaceuticals Co., Ltd., Alkem Laboratories Ltd., Supernus Pharmaceuticals, Inc., Eisai Co., Ltd., Abbott Laboratories, Upsher-Smith Laboratories, LLC., Pfizer Inc., H. Lundbeck A/s and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, administration route, treatment, distribution channel, end-user, and by region.

The solid dosage segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
West Syndrome Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying